Skip to main content

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration

Active, not recruiting · Not applicable · NCT03348995

Conditions: Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture

At a glance

Research payments reported, 2025
$127,492
U.S. investigators named
7
Sites paid
7
Planned or actual enrollment
250

About the trial

Sponsor
Miach Orthopaedics
Tested
Bridge-Enhanced ACL Restoration (BEAR) (device)
Dates
Started 2018-04-17; completion 2034-04-17
Results posted
Not yet

Bridge-Enhanced ACL Restoration (BEAR) is a new procedure being developed to treat patients with ACL injuries. In the BEAR procedure, an implant is placed between the torn ends of the ACL and the patient's own blood is added to the implant to stimulate ligament healing. We propose the current study to determine if older patients do better than younger patients (or vice versa) with this procedure. This is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL repair (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery. Additional objectives are to determine th…

From ClinicalTrials.gov, last updated 2026-06-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Miach Orthopaedics, Inc. reported $127,492 in research payments for this study in 2025 (7 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.